Could a tailored diet beat standard care for Crohn's flare-ups?
NCT ID NCT06953791
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares quality of life in adults with Crohn's disease during a flare when treated either with standard care or an adapted Crohn's disease exclusion diet plus partial enteral nutrition. The diet limits certain foods and uses a nutritional drink (Modulen) to help control inflammation. Researchers will track symptoms and well-being over 48 weeks to see if the diet approach offers better outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- adapted Crohn's disease exclusion diet with partial enteral nutrition (Modulen)
- What this could lead to
- If successful, this diet-based approach could offer a well-tolerated, drug-sparing option to manage Crohn's flares and improve quality of life.
- What could go wrong
- This is a small Phase 2 trial (52 participants), so results may not apply broadly. The diet is demanding, and adherence may be challenging.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Universitätsklinik Tübingen
RECRUITINGTübingen, 72076, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a patient registry unlock the secrets of IBD?
- Can we predict how kids with IBD will respond to treatment?
- Can switching IBD meds heal the gut when symptoms are quiet?
- Can a milk sugar tame IBD symptoms?
- Could an extra flu shot shield vulnerable kids?
- Can a Real-World study reveal the staying power of guselkumab?